- The Top-Rated Credit Cards in the US
- 17 Remarkably Easy Ways to Raise Holiday Shopping Cash
- The Restless Project: How Much Money Do You Really Need? Let’s start with $100K
- JPMorgan Chase, Other Big Banks Fall Prey to Hackers
- What Cable Mergers Might Mean for Your Television Service
- The Scary Way a Friend Request Can Lead to Identity Theft
- Am I Responsible for My Adult Son’s Medical Bills If He’s on My Insurance?
- Wireless Carriers Duke It Out With Unlimited Data Plans
The Boston Globe has a report on the case of the Reckis family, whose daughter Samantha suffered a severe allergic reaction to Children’s Motrin (the pain reliever, ibuprofen) a decade ago.
She’s now 17, legally blind, and unable to walk more than the length of a football field without becoming physically exhausted. But she’ll now likely receive $50 million (and each of her parents, $6.5 million) from Johnson & Johnson, the company who made the product.
A jury recently found the company didn’t properly warn about potential side effects on the over-the-counter version, and was therefore responsible for Reckis’ Toxic Epidermal Necrolysis. It’s a rare, but often deadly or permanently damaging, reaction to certain medications.
According to the article, the verdict must be upheld by a trial judge. If it is, and interest from the lengthy delay is included, the award could be worth over $100 million.